During the past decade, Dayton NCORP conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dayton NCORP" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "City of Hope National Medical Center" with 1 trials as a collaborator and "University of Chicago" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Dayton NCORP" are "Adult Solid Neoplasm" (1 trials), "Breast Carcinoma" (1 trials), "Cancer" (1 trials), "Fatigue" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Dayton NCORP" in a lesser frequency.

Most popular intervention types in "Dayton NCORP" are "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Comprehensive Geriatric Assessment" (1 trials), "Laboratory Biomarker Analysis" (1 trials), "Omega-3 Fatty Acid" (1 trials), "Placebo" (1 trials) and "Quality-of-Life Assessment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dayton NCORP" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dayton NCORP". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dayton NCORP, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dayton NCORP, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".